Novavax (NVAX) Reschedules Investor, Analyst Meeting; Wants to Finalize Resolve Trial Data

Novavax (NVAX) October 11 Meeting Date was 'Aggressive' - FBR Says

FBR Capital analyst Vernon Bernardino weighed in on Novavax (NASDAQ: NVAX), which is down 5% mid-day on investors concerns after the company rescheduled its annual investor meeting from next Tuesday, October 11, to Wednesday, November 9.

Bernardino said the event was highly anticipated to provide additional details on... More